GALNS (Galactosamine (N-acetyl)-6-sulfate Sulfatase (Morquio Syndrome, Mucopolysaccharidosis Type IVA), GALNAC6S, GAS, MPS4A, Chondroitinase) (Control Peptide)[GALNS]

General information
 

Name:
GALNS (Galactosamine (N-acetyl)-6-sulfate Sulfatase (Morquio Syndrome, Mucopolysaccharidosis Type IVA), GALNAC6S, GAS, MPS4A, Chondroitinase) (Control Peptide)[GALNS]
Size:
NA
Catalog no:
MBS658263
Price:
5 EUR
 

Additional extra details
 

  • Products_type

    Peptide

    Tissue

    control

    Disease

    syndrome

  • Description

    N terminal acetylation or CH3CO as epigenetic regulation of GALNS (Galactosamine (N- )-6-sulfate Sulfatase (Morquio Syndrome, Mucopolysaccharidosis IVA) GALNAC6S, GAS, MPS4A, Chondroitinase) (Control Peptide)[GALNS] by NATs.Isotype or positive controls by peptides, antibodies and deactivated samples.Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.